Accord Healthcare Recalls Levothyroxine Sodium Tablets Over Potency Issues
Accord Healthcare recalled 54,432 bottles of Levothyroxine Sodium Tablets on September 16, 2025. The tablets were found to be subpotent during stability testing. Consumers should stop using the product immediately and seek guidance from healthcare providers.
Product Details
The recall involves Levothyroxine Sodium Tablets, USP, 88 mcg, packaged in bottles of 90 tablets. The affected lot number is D2300045, with an expiration date of December 31, 2025. These products were distributed nationwide.
The Hazard
The tablets were tested and found to have assay content below the approved specification range. This subpotency can lead to inadequate treatment for patients requiring thyroid hormone replacement.
Reported Incidents
No specific incidents or injuries have been reported related to this recall. However, the risk of inadequate treatment remains a serious concern.
What to Do
Stop using the recalled Levothyroxine Sodium Tablets immediately. Contact Accord Healthcare or your healthcare provider for further guidance and potential arrangements for return and refund.
Contact Information
For more information, contact Accord Healthcare at 1-800-XXXX-XXXX or visit their website at www.accordhealthcare.com.